Use of drugs with anticholinergic effect and impact on cognition in Parkinson's disease: a cohort study

被引:175
作者
Ehrt, Uwe [1 ]
Broich, Karl [4 ]
Larsen, Jan Petter [2 ,3 ]
Ballard, Clive [5 ]
Aarsland, Dag [6 ]
机构
[1] Stavanger Univ Hosp, Psychiat Clin, Dept Psychiat, N-4095 Stavanger, Norway
[2] Stavanger Univ Hosp, Norwegian Ctr Movement Disorders, N-4095 Stavanger, Norway
[3] Stavanger Univ Hosp, Dept Neurol, N-4095 Stavanger, Norway
[4] Fed Inst Drugs & Med Devices BfArM, Bonn, Germany
[5] Kings Coll London, Wolfson Ctr Age Related Dis, London WC2R 2LS, England
[6] Univ Bergen, Inst Clin Med, Bergen, Norway
关键词
LEWY BODIES; CHOLINERGIC DYSFUNCTION; ALZHEIMERS-DISEASE; FOLLOW-UP; DEMENTIA; IMPAIRMENT; DEPRESSION; RISK; DELIRIUM; MEDICATIONS;
D O I
10.1136/jnnp.2009.186239
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background Cognitive decline is common in Parkinson's disease (PD). Although some of the aetiological factors are known, it is not yet known whether drugs with anticholinergic activity (AA) contribute to this cognitive decline. Such knowledge would provide opportunities to prevent acceleration of cognitive decline in PD. Objective To study whether the use of agents with anticholinergic properties is an independent risk factor for cognitive decline in patients with PD. Methods A community-based cohort of patients with PD (n=235) were included and assessed at baseline. They were reassessed 4 and 8 years later. Cognition was assessed using the Mini-Mental State Examination (MMSE). A detailed assessment of the AA of all drugs prescribed was made, and AA was classified according to a standardised scale. Relationships between cognitive decline and AA load and duration of treatment were assessed using bivariate and multivariate statistical analyses. Results More than 40% used drugs with AA at baseline. During the 8-year follow-up, the cognitive decline was higher in those who had been taking AA drugs (median decline on MMSE 6.5 points) compared with those who had not taken such drugs (median decline 1 point; p=0.025). In linear regression analyses adjusting for age, baseline cognition and depression, significant associations with decline on MMSE were found for total AA load (standardised beta=0.229, p=0.04) as well as the duration of using AA drugs (standardised beta 0.231, p=0.032). Conclusion Our findings suggest that there is an association between anticholinergic drug use and cognitive decline in PD. This may provide an important opportunity for clinicians to avoid increasing progression of cognitive decline by avoiding drugs with AA. Increased awareness by clinicians is required about the classes of drugs that have anticholinergic properties.
引用
收藏
页码:160 / 165
页数:6
相关论文
共 37 条
[1]   The rate of cognitive decline in Parkinson disease [J].
Aarsland, D ;
Andersen, K ;
Larsen, JP ;
Perry, R ;
Wentzel-Larsen, T ;
Lolk, A ;
Kragh-Sorensen, P .
ARCHIVES OF NEUROLOGY, 2004, 61 (12) :1906-1911
[2]   Neuropathology of dementia in Parkinson's disease: A prospective, community-based study [J].
Aarsland, D ;
Perry, R ;
Brown, A ;
Larsen, JP ;
Ballard, C .
ANNALS OF NEUROLOGY, 2005, 58 (05) :773-776
[3]   EFFECTS OF CHOLINERGIC BLOCKADE ON LANGUAGE IN HEALTHY-YOUNG WOMEN - IMPLICATIONS FOR THE CHOLINERGIC HYPOTHESIS IN DEMENTIA OF THE ALZHEIMER-TYPE [J].
AARSLAND, D ;
LARSEN, JP ;
REINVANG, I ;
AASLAND, AM .
BRAIN, 1994, 117 :1377-1384
[4]   Anticholinergic burden and the risk of falls among elderly psychiatric inpatients: A 4-year case-control study [J].
Aizenberg, D ;
Sigler, M ;
Weizman, A ;
Barak, Y .
INTERNATIONAL PSYCHOGERIATRICS, 2002, 14 (03) :307-310
[5]   Non-degenerative mild cognitive impairment in elderly people and use of anticholinergic drugs: longitudinal cohort study [J].
Ancelin, ML ;
Artero, S ;
Portet, F ;
Dupuy, AM ;
Touchon, J ;
Ritchie, K .
BMJ-BRITISH MEDICAL JOURNAL, 2006, 332 (7539) :455-458
[6]   Risk profiles for mild cognitive impairment and progression to dementia are gender specific [J].
Artero, S. ;
Ancelin, M-L ;
Portet, F. ;
Dupuy, A. ;
Berr, C. ;
Dartigues, J-F ;
Tzourio, C. ;
Rouaud, O. ;
Poncet, M. ;
Pasquier, F. ;
Auriacombe, S. ;
Touchon, J. ;
Ritchie, K. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2008, 79 (09) :979-984
[7]   Cholinesterase inhibitors reduce cortical Aβ in dementia with Lewy bodies [J].
Ballard, C. G. ;
Chalmers, K. A. ;
Todd, C. ;
McKeith, I. G. ;
O'Brien, J. T. ;
Wilcock, G. ;
Love, S. ;
Perry, E. K. .
NEUROLOGY, 2007, 68 (20) :1726-1729
[8]   Neuroleptics are associated with more severe tangle pathology in dementia with Lewy bodies [J].
Ballard, CG ;
Perry, RH ;
McKeith, IG ;
Perry, EK .
INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2005, 20 (09) :872-875
[9]   Cortical cholinergic denervation is associated with depressive symptoms in Parkinson's disease and parkinsonian dementia [J].
Bohnen, N. I. ;
Kaufer, D. I. ;
Hendrickson, R. ;
Constantine, G. M. ;
Mathis, C. A. ;
Moore, R. Y. .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2007, 78 (06) :641-643
[10]   Dementia and survival in Parkinson disease - A 12-year population study [J].
Buter, T. C. ;
van den Hout, A. ;
Matthews, F. E. ;
Larsen, J. P. ;
Brayne, C. ;
Aarsland, D. .
NEUROLOGY, 2008, 70 (13) :1017-1022